As a privately-held medical device company, SuperDimension focuses on developing and marketing minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease. Their product line, the i·LogicTM System, includes both capital equipment and disposables, catering to a market of over 8 million patients. With a mission to be the world leader in the diagnosis and treatment of distal lung disease, SuperDimension aims to enhance traditional bronchoscopy tools, allowing physicians to diagnose previously inaccessible lung lesions at an earlier stage, when they are more manageable. Their products enable physicians to access peripheral lung lesions and mediastinal lymph nodes, trace distal locations in the lungs, and reconstruct the bronchial airways, providing valuable tools for improved patient care.